Citeline (formerly Pharma Intelligence) powers a full suite of complementary business intelligence offerings to meet the evolving needs of health science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial, and regulatory related-decisions and create real-world opportunities for growth. Citeline’s global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and MedTech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more.
Employees: 201-500
Founded date: 1997
Investors 1
| Date | Name | Website |
| 22.07.2022 | Warburg Pi... | warburgpin... |
Mentions in press and media 8
| Date | Title | Description |
| 17.08.2024 | The Trust Gap in Indian Sustainable Investing | In the bustling world of finance, sustainability is the new gold standard. Investors are increasingly looking for ways to align their portfolios with ethical practices. In India, this trend is no different. A recent study reveals a stark re... |
| 13.08.2024 | Citeline Launches AI-Powered Tools for Clinical Trials | What You Should Know: – Citeline, a provider of intelligence solutions for the life sciences industry, today announced the launch of Protocol SmartDesign and Investigator SmartSelect, two new AI-powered tools designed to streamline and opti... |
| 15.06.2023 | Hemophilia Federation of America Launches Clinical Trial Finder Powered by Citeline Connect | NEW YORK (PRWEB) June 15, 2023 In an effort to make relevant clinical trials more accessible to patients, the Hemophilia Federation of America (HFA) has launched a clinical trial finder website. The trial finder, powered by Citeline Connect... |
| 01.12.2022 | Citeline Announces Winners of the 2022 Scrip Awards, Recognizing Accomplishments in Healthcare | LONDON (PRWEB) December 01, 2022 At a live ceremony held Wednesday night in London, Citeline announced the winners of the annual Scrip Awards, recognizing the outstanding accomplishments of those improving human healthcare worldwide. Now in... |
| 29.06.2022 | Norstella and Citeline plan merger, seek to bring critical medications to patients faster | Norstella and Citeline plan merger, seek to bring critical medications to patients faster Norstella, an organization that helps life sciences companies navigate the complexities of the drug life cycle, and Citeline (formerly Pharma Intellig... |
| 28.06.2022 | Citeline and Norstella Unite to Offer Life Sciences Clients a Full Suite of Commercial and Clinical Solutions | The new organization will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to patient June 28, 2022 – Norstella, an organization that helps life sciences ... |
| 29.06.2016 | What will separate the winners and the losers in the immuno-oncology R&D race? | But it does raise long term strategic and capital allocation questions for cancer R&D. This blog has raised this topic a few times in the past five years. In a 2012 post, The March of the Lemmings, the a huge amount of work on a small s... |
| - | What will separate the winners and the losers in the immuno-oncology R&D race? | I/O: The strategic supernova in cancer today With the big cancer confab ASCO 2016 fading into memory, R&D teams everywhere are getting back to work on their cancer programs – and across the industry many of them will be doing the same w... |